Xiang Cheng Zhang

Biography

Prof. Xiang Zhang, Royal Society Industry Fellow at University of Cambridge, has over 34 years combined academia (17 years) and industrial (17 years) experience in materials science and biosensors science and technology. Prof. Zhang is Principal Consultant and Head of Medical Materials & Devices of Lucideon. Zhang’s industry experience was gained in leading an international healthcare company, where, as Principal Scientist and Principal Technologist, his work covered almost all aspects of min-medical devices (such as biosensors) from R&D and manufacturing support to failure analysis and QC. Zhang also worked as Director of a technology company, in the field of nano-conductive materials and diagnostic medical devices.  In the last 3 years he has published three books “Inorganic Biomaterials” (2015), “Inorganic Controlled Release Technology” (2016) and “Science and Principles of Biodegradable and Bioresorbable Medical Polymers” (2017. As a materials scientist, he is passionate on “Science for Industry “and believes fundamental but applied sciences are the keys to solve industrial problems as well as develop good products that are much-needed by the society.  Prof. Zhang undertook his PhD and postdoctoral research at Cranfield University where he studied materials physics and nano/micro-mechanics and fracture mechanics of polymeric hybrids (organic and inorganic).  After spending a further four years on research for industrial applications, he was awarded an industrial fellowship at the University of Cambridge in 1995, where he carried out research on polymer ductile to brittle transition employing synchrotron X-ray (SAXS, WAXS) to study in situ deformation and fracture at nanometre scales, the results of which lead to completion of ductile to brittle transition theories in view of nano-mechanics and nano-fracture mechanics 1st time in the world.

Research Interest

  Sensor Technology  Biosensors - Mini-medical Devices Healthcare is seen increasingly expensive.  Majority cost is for hospitals.  To make people rely on hospitals less for diagnostics, biosensor technology for home use and POC is one way forward with advantage of speed, sensitivity and, above all, simplicity. Current research include glucose biosensor (also including cholesterol, triglyceride, HbA1c (glycosylated haemoglobin), uric acid, lactate, H2O2, blood gas); cardiovascular sensors to monitor heart health conditions; warble medical devices etc.